Drug
Liposomal Docetaxel clinical trials
A product of Docetaxel; its studies count on that page too.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses Liposomal Docetaxel is read from its arms, and is right about nine times in ten.
Testing it · 3
- Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate CancerWithdrawnPhase 2INSYS Therapeutics IncNCT01188408Written as Liposome Entrapped Docetaxel (LE-DT)
- Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic CancerCompletedPhase 2INSYS Therapeutics IncNCT01186731Written as Liposome Entrapped Docetaxel (LE-DT)
- Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid TumorsCompletedPhase 1INSYS Therapeutics IncNCT01151384Written as LE-DT